Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Becton, Dickinson and Company (BDX) Market Cap & Valuation Ratios

Becton, Dickinson and Company (BDX) has a market cap of $54.2B, a trailing P/E of 59.9 and a price-to-sales ratio of 2.5, with earnings according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

BDXBecton, Dickinson and CompanyFollow BDX — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
54.2B
P/E TTM
59.9
Dividend yield
2.1%
52-week
—
Next earnings
5 Nov, in 12 days

Peers

medical instruments & supplies · nearest by market cap · trailing 12 months
CompanyMkt cap, $BP/EEV/SalesEV/EBITDAFCF yieldRev. growthOp. marginROIC
BDX5459.93.213.94.9%+8%12%6%
ISRG15754.813.237.12.3%+20%28%20%
MDLN45—1.819.33.4%+11%6%7%
RMD3624.26.317.14.5%+10%33%27%
WST2850.28.231.81.6%+12%20%20%
SOLV15—2.37.4-0.8%-0.9%25%17%
BAX13—1.830.06.2%+5%-2%-2%
AVTR12—2.3128.63.9%-2%-5%-3%
COO12—3.315.15.8%+5%13%3%
ALGN1126.92.412.35.8%+4%13%13%
RGEN10.0242.412.467.81.1%+16%8%3%
Median of these 1050.22.824.63.7%+8%13%10%

P/E 59.9 vs. a peer median of 50.2; EV/Sales 3.2 vs. 2.8. BDX's own P/E sits at the 100th percentile of its history.

Growth vs. price

each dot a company · hover or tap for values
20501002000%+10%+20%revenue growth, TTM →P/E (log)BDXISRGRMDWSTALGNRGEN

MDLN and SOLV and BAX and AVTR and COO have no P/E (earnings not positive) and are left out · hover or tap a dot for values.

Becton, Dickinson and Company — questions

What is Becton, Dickinson and Company's market cap?
$54.2B.
What is Becton, Dickinson and Company's P/E ratio?
59.9 on trailing twelve-month earnings to 2026-06-30.
What is Becton, Dickinson and Company's price-to-sales ratio?
2.5.

Every figure on this page comes from Becton, Dickinson and Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.